Conley Chee
Amministratore Delegato presso SYROS PHARMACEUTICALS, INC.
Patrimonio netto: 116 121 $ in data 30/06/2024
Profilo
Conley Chee is currently the President, Chief Executive Officer & Director at Syros Pharmaceuticals, Inc. Prior to this, he worked at Novartis Pharmaceuticals as the Global Head-Portfolio Management from 2018 to 2021.
Mr. Chee completed his undergraduate degree at the University of Alberta and holds an MBA from the Richard Ivey School of Business.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
05/04/2024 | 22 504 ( 0.08% ) | 116 121 $ | 30/06/2024 |
Posizioni attive di Conley Chee
Società | Posizione | Inizio |
---|---|---|
SYROS PHARMACEUTICALS, INC. | Amministratore Delegato | 02/12/2023 |
Precedenti posizioni note di Conley Chee
Società | Posizione | Fine |
---|---|---|
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Corporate Officer/Principal | 28/02/2021 |
Formazione di Conley Chee
Richard Ivey School of Business | Masters Business Admin |
University of Alberta | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SYROS PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Health Technology |
- Borsa valori
- Insiders
- Conley Chee